drugset / Trial / NCT02655380

Remifentanil Requirement for Acceptable Intubating Condition

NCT02655380

Phase 4 Completed 51 enrolled Ajou University School of Medicine
RandomizedParallel-groupDouble-blindSupportive care

Summary

Ketamine and opioid are known to improve the intubating condition, respectively. Combination of ketamine and opioid potentiate analgesic effect and give hemodynamic stability in complementary manner. Therefore, the combination use of ketamine and remifentanil could be useful for acceptable intubating condition in the general anesthesia without the use of neuromuscular blocking agent. Generally, induction dose of ketamine ranges between 1 and 2 mg. There was no report about the optimal dose of remifentanil with 1 or 2 mg ketamine induction dose for intubation without neuromuscular blocking agent. The investigators focus on remifentanil dose using Dixon's up and down method.

Timeline

Start
2017-06-19
Primary completion
2018-04-16
Completion
2018-04-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 1 mg
Subject Ketamine Small molecule 2 mg
Subject Remifentanil Small molecule

Indications

No indication recorded.